Editorial: Anticancer Potential of Artemisia annua

por Kolesar, Jill M., Seeberger, Peter H.
Publicado 2022

Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma

por Anand, Namrata, Peh, Keng Hee, Kolesar, Jill M.
Publicado 2023

CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer

por Gorski, Justin W., Ueland, Frederick R., Kolesar, Jill M.
Publicado 2020

MUTYH as an Emerging Predictive Biomarker in Ovarian Cancer

por Hutchcraft, Megan L., Gallion, Holly H., Kolesar, Jill M.
Publicado 2021

SYNE1 Mutation Is Associated with Increased Tumor Mutation Burden and Immune Cell Infiltration in Ovarian Cancer

por Harbin, Laura M., Lin, Nan, Ueland, Frederick R., Kolesar, Jill M.
Publicado 2023

Prioritization of family member sequencing for the detection of rare variants

por Sippy, Rachel, Kolesar, Jill M, Darst, Burcu F, Engelman, Corinne D
Publicado 2016

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted Therapy

por Harbin, Laura M., Gallion, Holly H., Allison, Derek B., Kolesar, Jill M.
Publicado 2022

Association of first primary cancer with risk of subsequent primary cancer among survivors of adult-onset cancers in Kentucky and Appalachian Kentucky

por Chen, Quan, Huang, Bin, Anderson, Abigail M., Durbin, Eric B., Arnold, Susanne M., Kolesar, Jill M.
Publicado 2023

Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis

por Myint, Zin W., Momo, Harry D., Otto, Danielle E., Yan, Donglin, Wang, Peng, Kolesar, Jill M.
Publicado 2020

Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells

por Burgess, Brian T., Anderson, Abigail M., McCorkle, J. Robert, Wu, Jianrong, Ueland, Frederick R., Kolesar, Jill M.
Publicado 2020

EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky

por Larson, Kara L., Huang, Bin, Chen, Quan, Tucker, Thomas, Schuh, Marissa, Arnold, Susanne M., Kolesar, Jill M.
Publicado 2020

Dendritic Cell Membrane-Derived Nanovesicles for Targeted T Cell Activation

por Harvey, Brock T., Fu, Xu, Li, Lan, Neupane, Khaga R., Anand, Namrata, Kolesar, Jill M., Richards, Christopher I.
Publicado 2022

KEAP1 Is Required for Artesunate Anticancer Activity in Non-Small-Cell Lung Cancer

por Hill, Kristen S., McDowell, Anthony, McCorkle, J. Robert, Schuler, Erin, Ellingson, Sally R., Plattner, Rina, Kolesar, Jill M.
Publicado 2021

Correlation Between Trough Level of Abiraterone and Prostate-Specific Antigen (PSA) Response in Metastatic Hormone-Sensitive Prostate Cancer

por Myint, Zin W., Kolesar, Jill M., McCorkle, Joseph Robert, Wu, Jianrong, Ellis, Carleton S., Otto, Danielle E., Wang, Peng
Publicado 2022

Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment

por McDowell, Anthony, Hill, Kristen S., McCorkle, Joseph Robert, Gorski, Justin, Zhang, Yilin, Salahudeen, Ameen A., Ueland, Fred, Kolesar, Jill M.
Publicado 2021

Prevalence of SARS-CoV-2 IgG antibodies in health care workers at a tertiary care academic medical center – An assessment of occupational infection risk

por Forster, Derek, Lin, Nan, Levens, Justin, Stone, Rachael, Berry, Scott, Durbin, Eric, Jennings, C. Darrell, DiPaola, Robert, Kolesar, Jill M.
Publicado 2021

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review

por Larson, Kara L., Huang, Bin, Weiss, Heidi L., Hull, Pam, Westgate, Philip M., Miller, Rachel W., Arnold, Susanne M., Kolesar, Jill M.
Publicado 2021

Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice

por Rives, Taylor A., Pavlik, Heather, Li, Ning, Qasrawi, Lien, Yan, Donglin, Pickarski, Justine, Dietrich, Charles S., Miller, Rachel W., Ueland, Frederick R., Kolesar, Jill M.
Publicado 2023

Case report: A unique presentation of a high-grade neuroepithelial tumor with EWSR1::PATZ1 fusion with diagnostic, molecular, and therapeutic insights

por Ene, Andre, Di, Jing, Neltner, Janna H., Pittman, Thomas, Arnold, Susanne M., Kolesar, Jill M., Villano, John L., Bachert, Sara E., Allison, Derek B.
Publicado 2023

DACH1 mutation frequency in endometrial cancer is associated with high tumor mutation burden

por Riggs, McKayla J., Lin, Nan, Wang, Chi, Piecoro, Dava W., Miller, Rachel W., Hampton, Oliver A., Rao, Mahadev, Ueland, Frederick R., Kolesar, Jill M.
Publicado 2020